itraconazole has been researched along with Esophagitis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (75.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, S; Ishibashi, H; Nishiyama, Y; Uchida, K; Yamaguchi, H | 1 |
| Abe, S; Hisajima, T; Hu, W; Ishibashi, H; Nishiyama, Y; Yamaguchi, H | 1 |
| Barbaro, G; Di Lorenzo, G | 1 |
| Barbarini, G; Barbaro, G; Di Lorenzo, G | 2 |
| Eichel, M; Helm, EB; Just-Nübling, G; Stille, W | 1 |
| Alcini, P; Barbarini, G; Barbaro, G; Calderon, W; Di Lorenzo, G; Grisorio, B | 1 |
| Evans, S; Leake, H; Ustianowski, AP | 1 |
4 trial(s) available for itraconazole and Esophagitis
| Article | Year |
|---|---|
Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Double-Blind Method; Esophagitis; Female; Fluconazole; Humans; Itraconazole; Male | 1995 |
Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Confidence Intervals; Double-Blind Method; Esophagitis; Esophagoscopy; Female; Fluconazole; Humans; Itraconazole; Male; Prognosis; Treatment Outcome | 1995 |
Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida Esophagitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Esophagitis; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Male; Patient Compliance; Treatment Failure | 1996 |
Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Double-Blind Method; Drug Therapy, Combination; Esophagitis; Esophagoscopy; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Treatment Outcome | 1996 |
4 other study(ies) available for itraconazole and Esophagitis
| Article | Year |
|---|---|
Oral administration of itraconazole solution has superior efficacy in experimental oral and oesophageal candidiasis in mice than its intragastric administration.
Topics: Administration, Oral; Animals; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Oral; Esophagitis; Female; Gastric Mucosa; Itraconazole; Mice; Mice, Inbred ICR; Solutions; Stomach | 2007 |
A murine model of esophageal candidiasis with local characteristic symptoms.
Topics: Administration, Oral; Animals; Antifungal Agents; Candida albicans; Candidiasis; Chlorpromazine; Disease Models, Animal; Dopamine Antagonists; Esophagitis; Female; Histocytochemistry; Itraconazole; Mice; Mice, Inbred ICR | 2007 |
[Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis; Candidiasis, Oral; Drug Resistance, Microbial; Esophageal Diseases; Esophagitis; Fluconazole; HIV Infections; Humans; Itraconazole; Retrospective Studies; Suspensions | 1996 |
Outpatient therapy of HIV-associated oral and oesophageal candidosis.
Topics: AIDS-Related Opportunistic Infections; Ambulatory Care; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Esophagitis; Fluconazole; Guidelines as Topic; Humans; Itraconazole; Ketoconazole; Medical Audit; Nystatin; Retrospective Studies | 1997 |